United States · FDA National Drug Code directory

CYCLOBENZAPRINE HYDROCHLORIDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
76420-830_2d48e425-7718-63fa-e063-6394a90ab107
Product NDC
76420-830
Form
TABLET, FILM COATED
Composition / generic term
cyclobenzaprine hydrochloride
Labeler
Asclemed USA, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20170531
Source listing expiry
20261231

Source-listed ingredients

  • CYCLOBENZAPRINE HYDROCHLORIDE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1000 TABLET, FILM COATED in 1 BOTTLE (76420-830-00) · 76420-830-00
  • 100 TABLET, FILM COATED in 1 BOTTLE (76420-830-01) · 76420-830-01
  • 500 TABLET, FILM COATED in 1 BOTTLE (76420-830-05) · 76420-830-05
  • 7 TABLET, FILM COATED in 1 BOTTLE (76420-830-07) · 76420-830-07
  • 120 TABLET, FILM COATED in 1 BOTTLE (76420-830-12) · 76420-830-12
  • 30 TABLET, FILM COATED in 1 BOTTLE (76420-830-30) · 76420-830-30
  • 60 TABLET, FILM COATED in 1 BOTTLE (76420-830-60) · 76420-830-60
  • 90 TABLET, FILM COATED in 1 BOTTLE (76420-830-90) · 76420-830-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →